Cardinal Health, Inc. (LON:0HTG)
| Market Cap | 35.46B |
| Revenue (ttm) | 174.31B |
| Net Income (ttm) | 1.19B |
| Shares Out | n/a |
| EPS (ttm) | 4.93 |
| PE Ratio | 29.88 |
| Forward PE | 19.78 |
| Dividend | 1.55 (0.78%) |
| Ex-Dividend Date | Oct 1, 2025 |
| Volume | 99 |
| Average Volume | 605 |
| Open | 199.40 |
| Previous Close | 199.31 |
| Day's Range | 196.02 - 200.20 |
| 52-Week Range | 114.74 - 218.17 |
| Beta | 0.64 |
| RSI | 51.97 |
| Earnings Date | Jan 29, 2026 |
About Cardinal Health
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.... [Read more]
Financial Performance
In 2025, Cardinal Health's revenue was $222.58 billion, a decrease of -1.87% compared to the previous year's $226.83 billion. Earnings were $1.56 billion, an increase of 83.22%.
Financial numbers in USD Financial StatementsNews
Notable ETF Outflow Detected - RWL, CVS, CAH, CI
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 Revenue ETF (Symbol: RWL) where we have detected an ap...
Cardinal Health, Inc. (CAH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Cardinal Health, Inc. (CAH) Presents at Evercore 8th Annual Healthcare Conference Transcript
Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve
LTH, CAH, LMAT and FLS emerge as high-coverage-ratio standouts for investors seeking sturdier balance-sheet safety into 2026.
4 Stocks With High Coverage Ratios Offer Safer Bets Going Into 2026
High coverage ratios and earnings growth make CAH, LTH, LMAT and FLS safer investment bets heading into 2026.
Potentially 12%-15% Consistent Income: Monthly Options Series (December 2025)
Selling options can generate 12-15% annual income but requires discipline, risk management, and due diligence. We explain why selling cash-covered puts and covered calls is a relatively safe choice fo...
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...
Cardinal Health (CAH) Is Up 2.00% in One Week: What You Should Know
Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is It Worth Investing in Cardinal (CAH) Based on Wall Street's Bullish Views?
The average brokerage recommendation (ABR) for Cardinal (CAH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after m...
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Cardinal (CAH) Upgraded to Buy: Here's Why
Cardinal (CAH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Stop Sleeping on These 3 Stocks (Seriously)
Cardinal Health gained nearly 74% year to date, and it has the potential to keep climbing. Loews doesn't own the most exciting portfolio of businesses, but the conglomerate has been steadily gaining o...
6 Healthcare Stocks With Strong Upward Momentum
Out with the old (tech), in with the new (healthcare). After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of...
6 Healthcare Stocks With Strong Upward Momentum
Out with the old (tech), in with the new (healthcare). After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of...
Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today
Cardinal Health (NYSE: CAH) has outperformed the market over the past 5 years by 17.13% on an annualized basis producing an average annual return of 30.39%. Currently, Cardinal Health has a market ca...
Cardinal Health, Inc. (CAH) Presents at UBS Global Healthcare Conference 2025 Transcript
Cardinal Health, Inc. (CAH) UBS Global Healthcare Conference 2025 November 11, 2025 8:45 AM ESTCompany ParticipantsMatt Sims - Vice President of Investor...
4 Value Stocks With Strong Interest Coverage as Markets Rebound
As Wall Street rebounds on hopes of a shutdown resolution, investors turn to value picks like LTH, CAH, MCK and FLS with strong interest coverage ratios.
Validea Detailed Fundamental Analysis - CAH
Below is Validea's guru fundamental report for CARDINAL HEALTH INC (CAH). Of the 22 guru strategies we follow, CAH rates highest using our Multi-Factor Investor model based on the published strategy o...
Are You Looking for a Top Momentum Pick? Why Cardinal Health (CAH) is a Great Choice
Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...
3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Cardinal Health: Quiet Transformation, Clear Buy
Wells Fargo Raises Price Target for Cardinal Health (CAH) to $221 | CAH Stock News
Wells Fargo Raises Price Target for Cardinal Health (CAH) to $221 | CAH Stock News
Cardinal Health (CAH) Boosts FY 2026 EPS Guidance
Cardinal Health (CAH) Boosts FY 2026 EPS Guidance